Skip to content
Search

Latest Stories

Sajid Javid shares agenda on healthcare reform; pharmacy bodies pledge support

The NHS is facing a range of long term challenges which needs to be countered with prevention, enhance personalized care and sustainable performance, health and social care secretary Sajid Javid said on Tuesday (March 8).

In his speech on healthcare reform at the Royal College of Physicians in London, he said: “We face some long-term challenges: how to keep the NHS focused on delivery while futureproofing it for changing demographics and disease; how to meet rising patient expectations and address the injustices of widespread disparities; and how to deal with an unsustainable financial trajectory while backing the brilliant people who work in health and care.”


Javid emphasized on three key points for healthcare reform – prevention, personalization and performance.

He said, prevention is not just about building a ‘national hospital service’ but a true ‘National Health Service’.

“The NHS spends vast sums treating people whose conditions are avoidable - and by some estimates 40 per cent of its costs go on treating preventable conditions.

“So I want us to shift to a new mode of operating – one that’s about helping the whole population to stay healthy, not just treating those who show up asking for help.”

He noted that primary care along with GPs, pharmacists and dentists must be at the heart of this new agenda on prevention.

The second point, personalization focuses on delivery of more personalised care, empowerment of patients and fulfilment of the technological leaps that was seen during the pandemic.

The third point, Performance emphasizes on ensuring the NHS delivers the British people the very best healthcare in the world.

THORRUN Thorrun Govind (Photo courtesy of RPS)

Welcoming Javid’s statement on recognizing pharmacists’ role at the heart of prevention, Royal Pharmaceutical Society England chair Thorrun Govind said: “Pharmacists working across the health service will be crucial to supporting the NHS recovery and how we transform services for the future.

“Medicines are the most common health intervention in the NHS and pharmacists will be central to supporting ambitions around personalized care, shared decision-making and ensuring best value for taxpayers.

“We also know that pharmacists will play a leading role personalized medicines and how we can identify and treat disease.

Govind said pharmacists can help manage growing demand on the NHS by supporting people with long-term conditions, but this must foster fresh thinking on service commissioning, including making the most of pharmacist independent prescribers.

She added that future reforms should “create the right incentives across primary and secondary care to drive integration and collaboration.”

“We also need to see sustained investment in the pharmacy workforce, supporting and upskilling existing staff and ensuring a pipeline of pharmacists for the future, as well as the accelerated roll-out of read-write access to patient records for pharmacists wherever they may work.”

Welcoming the secretary’s principles for healthcare reforms, Association of Independent Multiple Pharmacies chief executive Dr Leyla Hannbeck, said community pharmacy and all the staff working in it “are perfectly placed and trained to deliver them all.

“It’s an exciting and promising vision and community pharmacies are keen to be part of it. What we require now is the detail, what’s expected of us. We hope to be listened to and involved in the very early planning stages, not as in the past- just given sparse and ill thought through orders at the 11th hour.”

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less